| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +17.5K | 5.7% | $0.85 | +$14.9K |
| Sells | 2 | -289K | 94.3% | $0.90 | -$259K |
| Net | +2 | -272K | -88.6% | -$244K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Vivo Capital VIII, LLC | 10%+ Owner | $5.44M | -$83K | -1.5% | Nov 21, 2023 |
| Holdings A/S Novo | 10%+ Owner | $3.52M | Jul 13, 2022 | ||
| Edgar Engleman | Director | $1.97M | -$176K | -8.22% | Nov 29, 2023 |
| Edith A. Perez | Chief Medical Officer | $36.5K | +$1.96K | +5.67% | Mar 4, 2024 |
| William P. Quinn | President, CEO and CFO, Director | $34.5K | +$9.08K | +35.8% | Jul 23, 2024 |
| Sarah Nemec | VP, Finance and PAO | $10.8K | Jul 23, 2024 | ||
| Randall C. Schatzman | Chief Executive Officer, Director | $10.1K | +$1.96K | +24.1% | Mar 4, 2024 |
| Grant Yonehiro | Chief Operating Officer | $6.97K | +$1.96K | +39% | Jul 23, 2024 |
| Nicole Onetto | Director | Jun 12, 2024 | |||
| David Dornan | Chief Scientific Officer | Feb 18, 2022 | |||
| Brian O'callaghan | Director | Jun 12, 2024 | |||
| Jakob Dupont | Director | Sep 3, 2024 | |||
| Kathleen Laporte | Director | Jun 12, 2024 | |||
| Laura Berner | Director | Jun 12, 2024 | |||
| Frank D. Lee | Director | Jun 12, 2024 | |||
| James Healy | Director | Jun 12, 2024 | |||
| Richard A. Miller | Director | Jun 12, 2023 | |||
| Mahendra Shah | Director | Jun 12, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|